|

VET3-TGI Clinical Trials

1 actively recruiting trial across 1 location

No change since May 2026

Pipeline

Phase 1: 1

Top Sponsors

  • KaliVir Immunotherapeutics1

Indications

  • Merkel Cell Carcinoma of Skin1
  • Cutaneous Squamous Cell Carcinoma (CSCC)1
  • Melanoma Stage IV1
  • Squamous Cell Carcinoma1
  • Microsatellite Stable Colorectal Cancer1

Los Angeles, California1 trial

A Study of VET3-TGI in Patients With Solid Tumors

USC/Norris Comprehensive Cancer Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.